Skip to main content


Xenoport's cost-cutting tactics lead to buyout with hefty premium

The biotechnology company, which makes alcoholism drug Horizant, was acquired by privately held Arbor Pharmaceuticals for $467 million in cash, a price lower than at least one analyst expected.

Here's Why XenoPort (XNPT) Stock is Continuing to Surge Today

XenoPort (XNPT) shares are soaring Monday as Arbor Pharmaceuticals agreed to acquire the company in a deal valued at about $467 million.

XenoPort (XNPT) Stock Skyrockets, Arbor Pharmaceuticals Acquiring For $467 Million

XenoPort (XNPT) shares are soaring Monday on the announcement that Arbor Pharmaceuticals will buy the biopharmaceutical company in a deal valued at about$467 million.

5 stocks insiders love right now

Insiders at these companies have been scooping up shares of their own stock lately.

XenoPort (XNPT) Stock Advancing on Potential Sale

XenoPort (XNPT) stock is gaining on Friday morning as the company explores the possibility of selling its self.

Breaking News

Tips for Retirees to Deal with Falling Stocks and Bonds

The markets' slide particularly hurts retirees, who may have to sell some of their stocks and bonds to finance spending.

Your Car Will Likely Be More Expensive

Ford has recently cast a shadow over the auto industry.

Short Sellers Targeted Commodities in September

Short sellers reversed course and sold $19 billion of shorts in September.

Alphabet CEO Pichai Continues to Sound Alarm About the Economy

The parent company of Google and Youtube is preparing for a sharp deterioration in the health of the economy.